Literature DB >> 23542189

Reliability and validity of the TIMPSI for infants with spinal muscular atrophy type I.

Kristin J Krosschell1, Jo Anne Maczulski, Charles Scott, Wendy King, Jill T Hartman, Laura E Case, Donata Viazzo-Trussell, Janine Wood, Carolyn A Roman, Eva Hecker, Marianne Meffert, Maude Léveillé, Krista Kienitz, Kathryn J Swoboda.   

Abstract

PURPOSE: This study examined the reliability and validity of the Test of Infant Motor Performance Screening Items (TIMPSI) in infants with type I spinal muscular atrophy (SMA).
METHODS: After training, 12 evaluators scored 4 videos of infants with type I SMA to assess interrater reliability. Intrarater and test-retest reliability was further assessed for 9 evaluators during a SMA type I clinical trial, with 9 evaluators testing a total of 38 infants twice. Relatedness of the TIMPSI score to ability to reach and ventilatory support was also examined.
RESULTS: Excellent interrater video score reliability was noted (intraclass correlation coefficient, 0.97-0.98). Intrarater reliability was excellent (intraclass correlation coefficient, 0.91-0.98) and test-retest reliability ranged from r = 0.82 to r = 0.95. The TIMPSI score was related to the ability to reach (P ≤ .05).
CONCLUSION: The TIMPSI can reliably be used to assess motor function in infants with type I SMA. In addition, the TIMPSI scores are related to the ability to reach, an important functional skill in children with type I SMA.

Entities:  

Mesh:

Year:  2013        PMID: 23542189      PMCID: PMC4381541          DOI: 10.1097/PEP.0b013e31828a205f

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  23 in total

1.  The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.

Authors:  Leslie Nelson; Hollis Owens; Linda S Hynan; Susan T Iannaccone
Journal:  Neuromuscul Disord       Date:  2006-05-02       Impact factor: 4.296

2.  The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation.

Authors:  Marion Main; Harvey Kairon; Eugenio Mercuri; Francesco Muntoni
Journal:  Eur J Paediatr Neurol       Date:  2003       Impact factor: 3.140

3.  134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands.

Authors:  E Bertini; A Burghes; K Bushby; B Estournet-Mathiaud; R S Finkel; R A C Hughes; S T Iannaccone; J Melki; E Mercuri; F Muntoni; T Voit; B Reitter; K J Swoboda; D Tiziano; E Tizzano; H Topaloglu; B Wirth; K Zerres
Journal:  Neuromuscul Disord       Date:  2005-10-03       Impact factor: 4.296

4.  Validity of the Test of Infant Motor Performance for discriminating among infants with varying risk for poor motor outcome.

Authors:  S K Campbell; D Hedeker
Journal:  J Pediatr       Date:  2001-10       Impact factor: 4.406

5.  Spinal muscular atrophy type 1: are proactive respiratory interventions associated with longer survival?

Authors:  Tara J Lemoine; Kathryn J Swoboda; Susan L Bratton; Richard Holubkov; Michael Mundorff; Rajendu Srivastava
Journal:  Pediatr Crit Care Med       Date:  2012-05       Impact factor: 3.624

6.  Reliability of 4 outcome measures in pediatric spinal muscular atrophy.

Authors:  Susan T Iannaccone; Linda S Hynan
Journal:  Arch Neurol       Date:  2003-08

7.  Construct validity of the test of infant motor performance.

Authors:  S K Campbell; T H Kolobe; E T Osten; M Lenke; G L Girolami
Journal:  Phys Ther       Date:  1995-07

Review 8.  Therapeutics development for spinal muscular atrophy.

Authors:  Charlotte J Sumner
Journal:  NeuroRx       Date:  2006-04

Review 9.  Population frequencies of inherited neuromuscular diseases--a world survey.

Authors:  A E Emery
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

10.  Reliability of hand-held dynamometry in spinal muscular atrophy.

Authors:  Luciano Merlini; Elena Stacy Mazzone; Alessandra Solari; Lucia Morandi
Journal:  Muscle Nerve       Date:  2002-07       Impact factor: 3.217

View more
  6 in total

Review 1.  Functional movement assessment with the Test of Infant Motor Performance.

Authors:  Suzann K Campbell
Journal:  J Perinatol       Date:  2021-04-21       Impact factor: 2.521

2.  Natural history of infantile-onset spinal muscular atrophy.

Authors:  Stephen J Kolb; Christopher S Coffey; Jon W Yankey; Kristin Krosschell; W David Arnold; Seward B Rutkove; Kathryn J Swoboda; Sandra P Reyna; Ai Sakonju; Basil T Darras; Richard Shell; Nancy Kuntz; Diana Castro; Julie Parsons; Anne M Connolly; Claudia A Chiriboga; Craig McDonald; W Bryan Burnette; Klaus Werner; Mathula Thangarajh; Perry B Shieh; Erika Finanger; Merit E Cudkowicz; Michelle M McGovern; D Elizabeth McNeil; Richard Finkel; Susan T Iannaccone; Edward Kaye; Allison Kingsley; Samantha R Renusch; Vicki L McGovern; Xueqian Wang; Phillip G Zaworski; Thomas W Prior; Arthur H M Burghes; Amy Bartlett; John T Kissel
Journal:  Ann Neurol       Date:  2017-12-08       Impact factor: 10.422

3.  Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study.

Authors:  Kristin J Krosschell; Michael Bosch; Leslie Nelson; Tina Duong; Linda P Lowes; Lindsay N Alfano; Danielle Benjamin; Terri B Carry; Ginger Devine; Carolyn Kelley; Rebecca Gadekan; Elizabeth C Malkus; Amy Pasternak; Stephanie Provance-Orr; Lynne Roemeiser-Logan; Alina Nicorici; Donata Trussell; Sally Dunaway Young; Jennifer R Fetterman; Jacqueline Montes; Penny J Powers; Rebecca Quinones; Janet Quigley; Christopher S Coffey; Jon W Yankey; Amy Bartlett; John T Kissel; Stephen J Kolb
Journal:  J Neuromuscul Dis       Date:  2018

4.  Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.

Authors:  Stephen J Kolb; Christopher S Coffey; Jon W Yankey; Kristin Krosschell; W David Arnold; Seward B Rutkove; Kathryn J Swoboda; Sandra P Reyna; Ai Sakonju; Basil T Darras; Richard Shell; Nancy Kuntz; Diana Castro; Susan T Iannaccone; Julie Parsons; Anne M Connolly; Claudia A Chiriboga; Craig McDonald; W Bryan Burnette; Klaus Werner; Mathula Thangarajh; Perry B Shieh; Erika Finanger; Merit E Cudkowicz; Michelle M McGovern; D Elizabeth McNeil; Richard Finkel; Edward Kaye; Allison Kingsley; Samantha R Renusch; Vicki L McGovern; Xueqian Wang; Phillip G Zaworski; Thomas W Prior; Arthur H M Burghes; Amy Bartlett; John T Kissel
Journal:  Ann Clin Transl Neurol       Date:  2016-01-21       Impact factor: 4.511

5.  Developmental milestones in type I spinal muscular atrophy.

Authors:  Roberto De Sanctis; Giorgia Coratti; Amy Pasternak; Jacqueline Montes; Marika Pane; Elena S Mazzone; Sally Dunaway Young; Rachel Salazar; Janet Quigley; Maria C Pera; Laura Antonaci; Leonardo Lapenta; Allan M Glanzman; Danilo Tiziano; Francesco Muntoni; Basil T Darras; Darryl C De Vivo; Richard Finkel; Eugenio Mercuri
Journal:  Neuromuscul Disord       Date:  2016-10-05       Impact factor: 4.296

6.  Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy - A pilot study.

Authors:  Teresa Kruse; Raoul Heller; Brunhilde Wirth; Julia Glöggler; Claudia D Wurster; Albert C Ludolph; Bert Braumann
Journal:  Acta Myol       Date:  2020-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.